http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011506324-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00
filingDate 2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011506324-A
titleOfInvention Intermediates and methods for making zeralenone macrolide analogs
abstract For example, formula (IV) Disclosed herein are methods and intermediates useful in the preparation of the compounds of In formula (IV), R 1 to R 12 are as defined in this specification. In another aspect, the invention relates to a method of making a composition of increased purity containing a compound of formula (IV). A composition with increased purity uses a starting material with the appropriate stereochemistry and is therefore enriched in an alpha enriched intermediate (eg, alpha comprising formula (V) or formula (VI)) It has also been determined by the present inventors that it can be obtained by targeting a crystalline intermediate that can be isolated in substantially pure form without performing chromatography. .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011506323-A
priorityDate 2007-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005023792-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011506323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010534682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008149244-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009015363-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10172827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58160470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468169541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467274602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423826672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467829865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468101677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467762582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426336708

Total number of triples: 34.